Skip to main content
Equibles

UBS Group AG

Position in SGMT — Sagimet Biosciences Inc.

CIK 1610520 ZURICH, V8
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,627,657
+$1,091,853 QoQ
Shares Held
339,930
+15.6% QoQ
Ownership
0.547%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 122 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 49% Shared 0% None 51%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. SGMT ranks #194 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in SGMT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,627,657 339,930
2026-03-31 $1,535,804 293,934
2025-12-31 $1,194,412 201,759
2025-09-30 $2,104,413 306,766
2025-06-30 $4,364,238 572,735
2025-03-31 $1,559,680 478,430
2024-12-31 $1,499,220 333,160
2024-09-30 $391,304 141,265
2024-06-30 $329,592 96,372
2024-03-31 $342,197 63,136
2023-12-31 $108,333 19,988
2023-09-30 $26,320 2,991